Medicare Enrolled
Dr. Jay Wang, M.D.
Medical Oncology · Naples, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wang? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wang
Dr. Jay Wang is a medical oncology in Naples, FL, with 18 years in practice. Based on federal Medicare data, Dr. Wang performed 427,249 Medicare services across 6,101 unique beneficiaries.
Between the years covered by Open Payments, Dr. Wang received a total of $118,610 from 111 pharmaceutical and/or device companies across 1705 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wang is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 2% volume in FL$ $118,610 industry payments
Medicare Practice Summary
Medicare Utilization ↗427,249
Medicare services
Top 2% in FL for medical oncology
6,101
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~23,736 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 129,540 | $0 | $4 |
| Pembrolizumab injection (Keytruda) | 38,200 | $43 | $137 |
| Denosumab injection (Prolia/Xgeva) | 33,540 | $18 | $51 |
| Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram | 33,120 | $1 | $3 |
| Azacitidine chemotherapy injection | 28,050 | $0 | $4 |
| Epoetin alfa injection (Procrit) for anemia | 25,010 | $6 | $23 |
| Anti-nausea injection (aprepitant) | 24,050 | $1 | $5 |
| Nivolumab injection (Opdivo) | 21,920 | $23 | $72 |
| Oxaliplatin chemotherapy injection | 14,846 | $0 | $12 |
| Daratumumab injection (Darzalex) | 14,400 | $38 | $110 |
| Filgrastim injection (Zarxio) for white blood cells | 11,520 | $0 | $2 |
| Paclitaxel chemotherapy injection | 9,538 | $0 | $2 |
| Injection, eflapegrastim-xnst, 0.1 mg | 5,676 | $25 | $116 |
| Dexamethasone injection (steroid) | 4,448 | $0 | $3 |
| Complete blood count (CBC) with differential | 4,048 | $8 | $29 |
| Blood draw (venipuncture) | 3,854 | $8 | $9 |
| Immune globulin infusion (Gammagard) | 3,082 | $36 | $108 |
| Injection, atropine sulfate, 0.01 mg | 2,800 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,500 | $1 | $28 |
| Office visit, established patient (30-39 min) | 2,343 | $99 | $339 |
| Injection, fulvestrant, 25 mg | 1,900 | $8 | $132 |
| Drug injection, under skin or into muscle | 1,644 | $11 | $69 |
| Anti-nausea injection (ondansetron/Zofran) | 1,304 | $0 | $9 |
| Administration of chemotherapy into vein, 1 hour or less | 846 | $102 | $378 |
| Injection, leucovorin calcium, per 50 mg | 796 | $3 | $12 |
| Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 744 | $85 | $642 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 638 | $23 | $84 |
| Injection, carboplatin, 50 mg | 601 | $2 | $41 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 592 | $50 | $189 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 569 | $3 | $205 |
| Injection, fluorouracil, 500 mg | 538 | $2 | $7 |
| Injection of additional new drug or substance into vein | 528 | $12 | $61 |
| Injection, zoledronic acid, 1 mg | 290 | $7 | $69 |
| Injection, diphenhydramine hcl, up to 50 mg | 284 | $1 | $3 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 272 | $58 | $206 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 228 | $134 | $562 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 224 | $26 | $89 |
| Administration of additional new drug or substance into vein, 1 hour or less | 224 | $52 | $178 |
| Office visit, established patient (20-29 min) | 219 | $63 | $239 |
| Injection, potassium chloride, per 2 meq | 200 | $0 | $4 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 186 | $1 | $6 |
| Administration of chemotherapy into vein, each additional hour | 176 | $22 | $79 |
| Red blood count, automated test | 174 | $4 | $10 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 163 | $17 | $59 |
| New patient office visit (45-59 min) | 160 | $127 | $453 |
| Injection of drug or substance into vein | 130 | $30 | $156 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 123 | $16 | $56 |
| Injection, magnesium sulfate, per 500 mg | 115 | $1 | $2 |
| Initial hospital admission, high complexity | 112 | $142 | $556 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 80 | $3 | $11 |
| New patient office visit (30-44 min) | 79 | $90 | $298 |
| Infusion, normal saline solution , 1000 cc | 73 | $2 | $7 |
| Automated urinalysis | 70 | $2 | $8 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 60 | $137 | $637 |
| Infusion into a vein for hydration, each additional hour | 59 | $10 | $42 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 59 | $16 | $56 |
| Application of on-body injector for under skin injection | 56 | $15 | $56 |
| Office visit, established patient (10-19 min) | 56 | $44 | $147 |
| Administration of additional new drug or substance into vein using push technique | 52 | $45 | $170 |
| Drawing of blood for a medical problem | 42 | $65 | $277 |
| Infusion into a vein for hydration, 31-60 minutes | 33 | $26 | $156 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 21 | $4 | $15 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 17 | $1 | $7 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 15 | $141 | $467 |
| Initial hospital admission, moderate complexity | 12 | $107 | $377 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
31.4% high complexity
65.8% medium
2.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$118,610
Total received (2018-2024)
Avg $16,944/year across 7 years
Top 8% in FL for medical oncology
111
Companies
1,705
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$52,589 (44.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$39,579 (33.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$26,443 (22.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$10,970
2023$13,090
2022$13,706
2021$14,799
2020$19,510
2019$38,457
2018$8,079
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$13,733
AstraZeneca Pharmaceuticals LP
$11,726
Janssen Biotech, Inc.
$7,001
Celgene Corporation
$5,967
Eisai Inc.
$4,556
Rigel Pharmaceuticals, Inc.
$4,496
Deciphera Pharmaceuticals Inc.
$3,952
Aurobindo Pharma USA, Inc.
$3,602
Ipsen Biopharmaceuticals, Inc
$3,522
EISAI INC.
$3,433
Verastem, Inc.
$3,281
GENZYME CORPORATION
$3,277
TAIHO ONCOLOGY, INC.
$3,074
ARRAY BIOPHARMA INC
$2,800
Spectrum Pharmaceuticals Inc.
$2,582
E.R. Squibb & Sons, L.L.C.
$2,497
Acceleron Pharma, Inc.
$2,470
AbbVie Inc.
$2,426
Takeda Pharmaceuticals U.S.A., Inc.
$2,183
Kite Pharma, Inc.
$1,914
PFIZER INC.
$1,892
Clovis Oncology, Inc.
$1,718
Pharmacyclics LLC, An AbbVie Company
$1,387
CTI BioPharma Corp.
$1,362
Epizyme, Inc.,
$1,331
Taiho Oncology, Inc.
$1,218
Genentech USA, Inc.
$1,215
Merck Sharp & Dohme Corporation
$1,177
Lilly USA, LLC
$1,154
AVEO Pharmaceuticals, Inc.
$1,121
ABBVIE INC.
$1,050
Merck Sharp & Dohme LLC
$1,047
Adaptive Biotechnologies Corporation
$982
Incyte Corporation
$981
Amgen Inc.
$810
Foundation Medicine, Inc.
$648
Regeneron Healthcare Solutions, Inc.
$640
Bayer HealthCare Pharmaceuticals Inc.
$587
Seagen Inc.
$552
Daiichi Sankyo Inc.
$544
NOVARTIS PHARMACEUTICALS CORPORATION
$513
Astellas Pharma US Inc
$458
BeiGene USA, Inc.
$419
GlaxoSmithKline, LLC.
$416
Alexion Pharmaceuticals, Inc.
$393
Gilead Sciences, Inc.
$362
Boehringer Ingelheim Pharmaceuticals, Inc.
$292
Alnylam Pharmaceuticals Inc.
$269
Novocure Inc.
$262
Exelixis Inc.
$255
Novocure GmbH
$250
JAZZ PHARMACEUTICALS INC.
$218
AbbVie, Inc.
$213
INTUITIVE SURGICAL, INC.
$192
Kyowa Kirin, Inc.
$191
Myriad Genetic Laboratories, Inc.
$182
Stemline Therapeutics Inc.
$181
Puma Biotechnology, Inc.
$158
Dova Pharmaceuticals
$155
Janssen Scientific Affairs, LLC
$145
TerSera Therapeutics LLC
$137
Agios Pharmaceuticals, Inc.
$137
Mirati Therapeutics, Inc.
$131
SERVIER PHARMACEUTICALS LLC
$122
SANOFI-AVENTIS U.S. LLC
$118
Seattle Genetics, Inc.
$109
G1 Therapeutics, Inc.
$106
Myovant Sciences Inc.
$106
Sobi, Inc
$104
Janssen Pharmaceuticals, Inc
$101
Teva Pharmaceuticals USA, Inc.
$99
PUMA BIOTECHNOLOGY, INC.
$99
PharmaEssentia USA Corporation
$97
Karyopharm Therapeutics Inc.
$94
SOBI, INC
$93
Pharmacyclics LLC, an AbbVie Company
$93
AMAG Pharmaceuticals, Inc.
$90
Pharmacosmos Therapeutics Inc.
$83
Bayer Healthcare Pharmaceuticals Inc.
$78
Heron Therapeutics, Inc.
$77
EUSA Pharma (US) LLC
$73
Sumitomo Pharma America, Inc.
$70
Sun Pharmaceutical Industries Inc.
$65
ADC Therapeutics America, Inc.
$63
MorphoSys, US Inc.
$62
Acrotech Biopharma LLC
$60
Dendreon Pharmaceuticals LLC
$60
EMD Serono, Inc.
$53
Jazz Pharmaceuticals Inc.
$51
Genmab U.S., Inc.
$47
Aveo Pharmaceuticals, Inc.
$44
Blueprint Medicines Corporation
$43
Sirtex Medical Inc
$40
Coherus Biosciences Inc.
$33
Secura Bio, Inc.
$33
INSYS Therapeutics Inc
$29
NanoString Technologies, Inc.
$28
Organogenesis Inc.
$25
SUN PHARMACEUTICAL INDUSTRIES INC.
$24
Acrotech Biopharma Inc.
$22
PORTOLA PHARMACEUTICALS, INC.
$22
Immunomedics, Inc.
$21
TG Therapeutics, Inc.
$21
Apellis Pharmaceuticals, Inc.
$20
Epizyme, Inc.
$20
Partner Therapeutics, Inc.
$19
Servier Pharmaceuticals LLC
$19
Shire North American Group Inc
$13
Emmaus Medical, Inc.
$13
Sysmex Inostics Inc
$11
Veracyte, Inc.
$4
Top 3 companies account for 27.4% of total payments
Associated products mentioned in payments ›
ABECMA · ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AMVUTTRA · ANDEXXA · AYVAKIT · Abraxane · Alecensa · Avastin · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Beleodaq · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CERDELGA · CEREZYME · CINVANTI · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Da Vinci Surgical System · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ERBITUX · ERLEADA · EVENITY · Empaveli · Endari · Enhertu · Epkinly · Erleada · FARYDAK · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · Folotyn · GAVRETO · GAZYVA · GILOTRIF · HYQVIA · Halaven · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INQOVI · INREBIC · Imbruvica · Inrebic · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Leukine · Lonsurf · Lunsumio · Luspatercept · MARQIBO · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYCHOICE CDX · MYLOTARG · MYRISK · Marqibo · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCREVUS · OJJAARA · ONIVYDE · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Odomzo · Oncology · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROSIGNA ASSAY · PROVENGE · PYRUKYND · Padcev · Perjeta · Phesgo · Polivy · Pomalyst · Poteligeo · Prolia · Puraply · QINLOCK · Quzyttir · REBLOZYL · RETEVMO · RYBREVANT · RYDAPT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · SYNDROS · Soliris · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecartus · Tibsovo · Trodelvy · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VONVENDI · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · YONSA (abiraterone acetate) · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · Zevalin · Zoladex · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (44%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 8% for medical oncology in FL.
Equivalent to $28 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
10
Per 100K population
2.6
County median income
$86,173
Nearest hospital
WILLOUGH AT NAPLES, THE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Wang is a mixed practice specialist, with above-average Medicare volume (top 2% in FL), and high industry engagement (consulting-driven, top 8%), with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Wang experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Wang performed 129,540 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wang receive payments from pharmaceutical companies?
Yes. Dr. Wang received a total of $118,610 from 111 companies across 1,705 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wang's costs compare to other medical oncologys in Naples?
Dr. Wang's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in Naples
Browse medical oncologys in Naples ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology